Washington, DC (PRWEB) April 08, 2014
At a time when many insurers and plan sponsors are working to decrease the rate of obesity in the U.S., Aetna Inc. has become the first insurer to collaborate with drug manufacturers on a pilot of new obesity treatments combined with lifestyle support. “Aetna’s Obesity Drug Pilot: Strategies to Improve Health Status and Lower Costs,” the April 17 webinar from Atlantic Information Services, Inc. (AIS), will explain the nuances of the innovative pilot project and the results Aetna hopes to achieve.
During this webinar, two top Aetna executives — Edmund Pezalla, M.D., M.P.H., vice president and national medical director for pharmaceutical policy and strategy, and Dan Conroy, head of business development for their CarePass platform — will provide 60 minutes of expert presentations followed by 30 minutes devoted to individual questions. Participants will get insider perspectives on key questions such as:
Visit http://aishealth.com/marketplace/c4m14_041714 for more details and registration information.
Atlantic Information Services, Inc. (AIS) is a publishing and information company that has been serving the health care industry for more than 25 years. It develops highly targeted news, data and strategic information for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. AIS products include print and electronic newsletters, websites, looseleafs, books, strategic reports, databases, webinars and conferences. Learn more at http://www.AISHealth.com.